Chemical Compound

2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-, (2Z)-2-butenedioate (1:1); 2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-, (Z)-2-butenedioate (1:1); 5-[[4-[2-(N-Methyl-N-2-pyridylamino)ethoxy]phenyl]methyl]thiazolidine-2,4-dione maleate; Avandia; BRL 49653C; Rosiglitazone maleate; BRL-49653C; SB214521; SB236833; SB237216; BRL 49653C

CAS Registry Number 155141-29-0
2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-, (2Z)-2-butenedioate (1:1); 2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-, (Z)-2-butenedioate (1:1); 5-[[4-[2-(N-Methyl-N-2-pyridylamino)ethoxy]phenyl]methyl]thiazolidine-2,4-dione maleate; Avandia; BRL 49653C; Rosiglitazone maleate; BRL-49653C; SB214521; SB236833; SB237216; BRL 49653C 结构式
Primary record

2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-, (2Z)-2-butenedioate (1:1); 2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-, (Z)-2-butenedioate (1:1); 5-[[4-[2-(N-Methyl-N-2-pyridylamino)ethoxy]phenyl]methyl]thiazolidine-2,4-dione maleate; Avandia; BRL 49653C; Rosiglitazone maleate; BRL-49653C; SB214521; SB236833; SB237216; BRL 49653C

库存
8,771 克
纯度
99.4 %
CAS
155141-29-0

化合物标识与属性

CAS
155141-29-0
PubChem CID
5281055
SMILES
CN(CCOC1=CC=C(C=C1)CC2C(=O)NC(=O)S2)C3=CC=CC=N3.C(=C\C(=O)O)\C(=O)O
Canonical SMILES
CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1.O=C(O)/C=C\C(=O)O

名称与同义词

  • Rosiglitazone maleate
  • Avandia
  • Avandaryl
  • Nyracta
  • 155141-29-0
  • Rosiglitazone XR
  • Venvia
  • rosiglitazone
  • Avandamet
  • Mixture Name
  • Rosiglitzazone maleate
  • Avandia (TN)
  • Rosiglitazone (maleate)
  • Rosiglitazonemaleate
  • Rosiglitazone Maleate [USAN]
  • AC1NQXYB
  • RefChem:56530
  • BRL 49653C
  • BRL-49653C
  • maleic acid; rosiglitazone
  • DTXSID2023569
  • MFCD03427306
  • (Z)-but-2-enedioic acid
  • CHEMBL843
  • D0K5ER
  • UNII-KX2339DP44
  • BRL 49653-C
  • BRL-49653-C
  • DTXCID703569
  • KX2339DP44
  • SCHEMBL19023
  • MLS001306472
  • MLS001401426
  • NSC-717764
  • SUFUKZSWUHZXAV-BTJKTKAUSA-N
  • CHEBI:8892
  • orb1307989
  • orb3025111
  • C18H19N3O3S.C4H4O4
  • SCHEMBL29376790
  • C22H23N3O7S
  • Rosiglitazone maleate (JAN/USP)
  • NSC717764
  • GLXC-05178
  • HMS2051B11
  • HMS2233I10
  • HMS3884H04
  • HMS5081E15
  • Rosiglitazone maleate (JAN/USAN)
  • ROSIGLITAZONE MALEATE [MI]
  • ROSIGLITAZONE MALEATE [JAN]
  • MSK10098
  • Rosiglitazone (maleate) (Standard)
  • Tox21_302367
  • AC-737
  • EBC-11276
  • HB4140
  • HY-14600R
  • NP3380
  • ROSIGLITAZONE MALEATE [VANDF]
  • s2505
  • Avandiaadministration for 6-12 weeks
  • ROSIGLITAZONE MALEATE [MART.]
  • AKOS015961534
  • ROSIGLITAZONE MALEATE [USP-RS]
  • ROSIGLITAZONE MALEATE [WHO-DD]
  • ACN-048754
  • Avandia administration for 6-12 weeks
  • CCG-100943
  • CCG-208126
  • CID5281055
  • CS-1692
  • CS-O-02261
  • FR27758
  • KS-5027
  • NC00193
  • NSC 717764
  • SB-206846
  • SB-210232
  • NCGC00255233-01
  • 5-(4-(2-(methyl(pyridin-2-yl)amino)ethoxy)benzyl)thiazolidine-2,4-dione maleate
  • AN-15585
  • BC207045
  • BR164376
  • CPD000471612
  • HY-14600
  • Rosiglitazone maleate - Bio-X trade mark
  • SAM001246610
  • SMR000471612
  • ROSIGLITAZONE MALEATE [ORANGE BOOK]
  • AB0073096
  • LS-173475
  • A4302
  • CAS-155141-29-0
  • NS00076223
  • ROSIGLITAZONE MALEATE [USP MONOGRAPH]
  • SW197573-4
  • C18-H19-N3-O3-S.C4-H4-O4
  • D00596
  • K-4902
  • Z-8295
  • EN300-1692904
  • 141R290
  • A809615
  • 2,4-Thiazolidinedione, 5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-, (2Z)-2-butenedioate (1:1)
  • (+-)-5-(p-(2-(Methyl-2-pyridylamino)ethoxy)benzyl)-2,4-thiazolidinedione maleate (1:1)
  • Q27888042
  • (2Z)-but-2-enedioic acid; 5-[(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}phenyl)methyl]-1,3-thiazolidine-2,4-dione
  • (Z)-but-2-enedioic acid;5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
  • 2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-, (2Z)-2-butenedioate (1:1)
  • 122320-73-4
  • 2,4-Thiazolidinedione,5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-,(2Z)-2-butenedioate
  • 5-[[4-[2-[Methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione maleate
  • 5-{[4-({2-[methyl(pyridin-2-yl)amino]ethyl}oxy)phenyl]methyl}-1,3-thiazolidine-2,4-dione (2Z)-but-2-enedioate
  • 2, 5-[[4-[2-(methyl-2-pyridinylamino) ethoxy]phenyl]methyl]-, (2Z)-2-butenedioate (1:1)
  • 5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
  • 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleate
  • 5-[4-[2-[N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleate
  • 5-[4-[2-[N-methyl-N-(2-pyridyl)amino]ethoxy]phenyl methyl]thiazolidine-2,4-dione maleate
  • 5-{4-[2-(Methylpyridin-2-ylamino)ethoxy]benzyl}thiazolidine-2,4-dione maleate
  • maleic acid; 5-[[4-[2-[methyl(2-pyridyl)amino]ethoxy]phenyl]methyl]thiazolidine-2,4-dione
  • maleic acid;5-[[4-[2-[methyl(2-pyridyl)amino]ethoxy]phenyl]methyl]thiazolidine-2,4-dione
  • (+ -)-5-[[4-2-(methyl]-2-pyridinylamino)ethoxy]phenyl]methyl]-2,4-thiazolidinedione,(Z)-2-butenedioate (1:1)
  • (+-)-5-((4-(2-(Methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione, (Z)-2-Butenedioate (1:1)
  • (+-)-5-[[4-2-(methyl]-2-pyridinylamino)ethoxy]phenyl]methyl]-2,4-thiazolidinedione,(Z)-2-butenedioate (1:1)
  • (+/-)-5-(P-(2-(METHYL-2-PYRIDYLAMINO)ETHOXY)BENZYL)-2,4-THIAZOLIDINEDIONE MALEATE (1:1)
  • (2Z)-But-2-enedioic acid--5-[(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}phenyl)methyl]-1,3-thiazolidine-2,4-dione (1/1)
  • (Z)-but-2-enedioate;2-[4-[(2,4-dioxo-1,3-thiazolidin-3-ium-5-yl)methyl]phenoxy]ethyl-methyl-pyridin-2-ylazanium
  • (Z)-but-2-enedioic acid; 5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
  • 1217260-35-9
  • 2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino) ethoxy]phenyl]methyl]-, (2Z)-2-butenedioate (1:1)
  • 2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-, (2Z)-2-butenedioate (1:1); 2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-, (Z)-2-butenedioate (1:1); 5-[[4-[2-(N-Methyl-N-2-pyridylamino)ethoxy]phenyl]methyl]thiazolidine-2,4-dione maleate; Avandia; BRL 49653C; Rosiglitazone maleate; BRL-49653C; SB214521; SB236833; SB237216; BRL 49653C
  • 5-((4-(2-(N-METHYL-N-2-PYRIDYLAMINO)ETHOXY)PHENYL)METHYL)THIAZOLIDINE-2,4-DIONE MALEATE
  • 5-[(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}phenyl)methyl]-1,3-thiazolidine-2,4-dione; but-2-enedioic acid
  • 5-[[4-[2-(Methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-2,4-thiazolidinedione (2Z)-2-butenedioate